Neonatal jaundice

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search
Neonatal jaundice
Classification and external resources
Infant undergoing home phototherapy for jaundice using a bili blanket
ICD-10 P58., P59.
ICD-9 773, 774
DiseasesDB 8881
MedlinePlus 001559
eMedicine ped/1061 

WikiDoc Resources for

Neonatal jaundice

Articles

Most recent articles on Neonatal jaundice

Most cited articles on Neonatal jaundice

Review articles on Neonatal jaundice

Articles on Neonatal jaundice in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Neonatal jaundice

Images of Neonatal jaundice

Photos of Neonatal jaundice

Podcasts & MP3s on Neonatal jaundice

Videos on Neonatal jaundice

Evidence Based Medicine

Cochrane Collaboration on Neonatal jaundice

Bandolier on Neonatal jaundice

TRIP on Neonatal jaundice

Clinical Trials

Ongoing Trials on Neonatal jaundice at Clinical Trials.gov

Trial results on Neonatal jaundice

Clinical Trials on Neonatal jaundice at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Neonatal jaundice

NICE Guidance on Neonatal jaundice

NHS PRODIGY Guidance

FDA on Neonatal jaundice

CDC on Neonatal jaundice

Books

Books on Neonatal jaundice

News

Neonatal jaundice in the news

Be alerted to news on Neonatal jaundice

News trends on Neonatal jaundice

Commentary

Blogs on Neonatal jaundice

Definitions

Definitions of Neonatal jaundice

Patient Resources / Community

Patient resources on Neonatal jaundice

Discussion groups on Neonatal jaundice

Patient Handouts on Neonatal jaundice

Directions to Hospitals Treating Neonatal jaundice

Risk calculators and risk factors for Neonatal jaundice

Healthcare Provider Resources

Symptoms of Neonatal jaundice

Causes & Risk Factors for Neonatal jaundice

Diagnostic studies for Neonatal jaundice

Treatment of Neonatal jaundice

Continuing Medical Education (CME)

CME Programs on Neonatal jaundice

International

Neonatal jaundice en Espanol

Neonatal jaundice en Francais

Business

Neonatal jaundice in the Marketplace

Patents on Neonatal jaundice

Experimental / Informatics

List of terms related to Neonatal jaundice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Neonatal jaundice is a yellowing of the skin and other tissues of a newborn infant caused by increased levels of bilirubin in the blood. Neonatal jaundice is usually harmless: this condition is often seen in infants around the second day after birth, lasting till day 8 in normal births, or to around day 14 in premature births. Serum bilirubin normally drops to a low level without any intervention required: the jaundice is presumably a consequence of metabolic and physiological adjustments after birth.

All jaundice should be medically evaluated before treatment can be given.

Causes

In neonates, benign jaundice tends to develop because of two factors - the breakdown of fetal hemoglobin as it is replaced with adult hemoglobin and the relatively immature hepatic metabolic pathways which are unable to conjugate and so excrete bilirubin as fast as an adult. This causes an accumulation of bilirubin in the body (hyperbilirubinemia), leading to the symptoms of jaundice.

Severe neonatal jaundice may indicate the presence of other conditions contributing to the elevated bilirubin levels, of which there are a large variety of possibilities (see below). These should be detected or excluded as part of the differential diagnosis to prevent the development of complications. They can be grouped into the following categories:

 
 
 
 
 
 
 
 
 
 
 
 
Neonatal jaundice
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Unconjugated bilirubin
 
 
 
 
 
 
 
Conjugated bilirubin
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pathologic
 
 
 
Physiologic
 
Hepatic
 
 
 
Post-hepatic
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hemolytic
 
 
 
Non-hemolytic
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Intrinsic causes
 
 
 
Extrinsic causes
 
 
 
 
 
 
 
 
 
 
 

Intrinsic causes of hemolysis

Extrinsic causes of hemolysis

Non-hemolytic causes

Hepatic causes

Post-hepatic

Treatment

Infants with neonatal jaundice are often treated with bili lights, exposing them to high levels of colored light to break down the bilirubin. This works due to a photo oxidation process occurring on the bilirubin in the subcutaneous tissues of the neonate. Light energy creates isomerization of the bilirubin and consequently transformation into compounds that the new born can excrete via urine and stools. Blue light is typically used for this purpose. Green light is more effective at breaking down bilirubin, but is not commonly used because it makes the babies appear sickly, which is disturbing to observers. A recent study has shown that light therapy may increase the risk of skin moles (or "nevi") in childhood which in turn also increases the risk of melanoma (skin cancer).[1][2]

Brief exposure to indirect sunlight each day and increased feeding are also helpful. A newborn should not be exposed to direct sunlight because of the danger of sunburn, which is much more harmful to a newborn's thin skin than that of an adult.

If the neonatal jaundice does not clear up with simple phototherapy, other causes such as biliary atresia, PFIC, bile duct paucity, Alagille's syndrome, alpha 1 and other pediatric liver diseases should be considered. The evaluation for these will include blood work and a variety of diagnostic tests. Prolonged neonatal jaundice is serious and should be followed up promptly.

Non-organic causes

Breast feeding jaundice

"Breastfeeding jaundice" is caused by insufficient milk intake resulting in dehydration, and can be prevented by frequent breastfeeding sessions of sufficient duration to stimulate adequate milk production.

Breast milk jaundice

Very rarely, "breast milk jaundice" occurs during the second or third week of life, and may be caused by high levels of beta-glucuronidase in breast milk. Neither condition is a reason to stop nursing, though caregivers may advise IV or other fluid administration to ensure the baby is not dehydrated.

Non-physiologic causes

A small percentage of infants will have "hemolytic jaundice". The infant's red blood cells will be broken down quicker because antibodies that attack the infant's red blood cells are transferred from the mother to the baby's bloodstream. The antibodies may be due to ABO (blood group) incompatibility or Rhesus factor differences. [3]

Rare causes

Rarely, neonatal jaundice may be caused by a genetic syndrome such as Crigler-Najjar syndrome.

Complications

With high doses of bilirubin (severe hyperbilirubinemia) there can be a complication known as kernicterus. This is the chief condition that treatment of jaundice is aimed at preventing. The effects of kernicterus range from fever, seizures, and a high-pitched crying to mental retardation. This is due to a staining effect on the basal ganglia leading to neuronal damage. With aggressive treatment such as exchange transfusion to lower very high bilirubin levels, the neurological effects are almost always transient.

See also

References

  1. Childhood Moles Linked to Neonatal Jaundice Treatment - CME Teaching Brief� - MedPage Today. Retrieved on 2007-06-30.
  2. Infant Jaundice Treatment May Encourage Moles - Skin diseases, conditions and procedures on MedicineNet.com. Retrieved on 2007-06-30.
  3. ABO Incompatibility. Retrieved on 2007-06-30. at About.com

External links

de:Neugeborenengelbsucht

WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch

Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

In other languages